n.laurent
TL2 · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 21 April 2025 · last posted 6d
66 posts, newest first. Showing up to 150.
-
A site rotation scheme that is easy enough to actually follow Replied, post #121 · Practice › Administration · 22 Jul 2026 · 3 likes Noted, and thank you for writing it out rather than summarising it.
-
Seven-day rolling means and why weekly readings mislead Replied, post #70 · Outcomes › Progress reports · 20 Jul 2026 · 2 likes Post #69 is the version of this I will quote in future. One addition. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Revisiting: The best-written scientific paper you have read Replied, post #100 · Lounge › Off topic · 18 Jul 2026 · 2 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. A single observation, in a thread that…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #80 · Analytics › Impurities & related substances · 15 Jul 2026 · 12 likes Relative response factors mean impurities are not detected in proportion to how much of them is present. A one per cent peak is not one per cent by mass unless the…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #14 · Compounds › Secretagogues & GH axis · 29 Jun 2026 · 3 likes This settles it for me, at least until somebody posts a reason it should not.
-
Coming back to: A structured critique template this community uses Replied, post #34 · Evidence › Study critique · 15 Jun 2026 · 0 likes Adding the measurement that post #31 says would settle it. Reading this structured critique template thread as someone who came in with a fixed view: the third and…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #17 · Compounds › Semaglutide · 6 Jun 2026 · 0 likes Picking up post #16: that is the part I would want checked first. The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #25 · Outcomes › Body composition · 24 May 2026 · 15 likes That is a fair summary of where the discussion has got to.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #42 · Compounds › Semaglutide · 23 Apr 2026 · 4 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #81 · Practice › Interactions · 8 Apr 2026 · 13 likes This follows post #78 rather than contradicting it. A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #105 · Regional › UK & Ireland · 4 Apr 2026 · 0 likes I have been on both sides of the pharmacy supply argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #9 · Practice › Dosing & titration · 30 Mar 2026 · 5 likes Research-use-only material is not a licensed product and no labelling covers it. Everything in this subcategory about published schedules describes what was done in…
-
Measurement error in a self-reported exposure Replied, post #20 · Evidence › Study critique · 22 Feb 2026 · 0 likes Building on post #17 rather than restating it. Measurement error was covered in the wiki last year and the page has a review date on it, which is a better starting…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #101 · Analytics › Mass spectrometry · 15 Feb 2026 · 10 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #51 · Evidence › Study critique · 13 Feb 2026 · 2 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #37 · Practice › Reconstitution · 1 Feb 2026 · 19 likes Helpful, and short, which on this subject is harder than long.
-
Research-use-only labelling: what it means and what it does not Replied, post #91 · Sourcing › Regulatory · 22 Jan 2026 · 9 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #16 · Clinical › Special populations · 16 Jan 2026 · 31 likes Post #13 is right about the mechanism and I think understates the practical bit. Dedicated trials in under-studied populations are the only real remedy and several are…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #15 · Data & Tools › Datasets · 15 Jan 2026 · 13 likes A codebook describing each field takes twenty minutes and is what makes the file usable by anyone but you. Most shared datasets here do not have one.
-
A single out-of-range value on an otherwise normal panel Replied, post #5 · Clinical › Bloodwork · 13 Jan 2026 · 32 likes Narrowing post #3, because the general version has more than one answer. A trend needs at least three points to be a trend. Two points are a line and a line through…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #111 · Practice › Side effects · 30 Dec 2025 · 0 likes Confirming post #108 from a second method, which matters more than confirming it from a second person. Dehydration is the mechanism behind more of the secondary…
-
Absence of evidence and evidence of absence Replied, post #9 · Research Methods › Statistics · 15 Dec 2025 · 11 likes On post #5 — agreed on the reasoning, with one qualification. Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #83 · Compounds › Other compounds · 25 Nov 2025 · 0 likes Posting my Sequence verification numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #61 · Practice › Reconstitution · 25 Nov 2025 · 24 likes No notes. Posting so the count is not one.
-
Lyophilisation and why the cake looks the way it does Replied, post #26 · Pharmacology › Formulation chemistry · 23 Nov 2025 · 0 likes The number people quote for lyophilisation is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Citation sweep results: how many references did not say what was claimed Replied, post #9 · Meta › Wiki maintenance · 23 Nov 2025 · 0 likes Post #6 answers the question as asked. The question underneath it is different. Careful with that. A short duplicated paragraph is sometimes better than a link, because…
-
DXA precision and the least significant change for lean mass Replied, post #4 · Outcomes › Body composition · 16 Nov 2025 · 19 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
[2026 update] What steady state means for the decision to escalate Replied, post #95 · Practice › Dosing & titration · 15 Nov 2025 · 0 likes Narrowing post #92, because the general version has more than one answer. The most useful reply I ever got about steady state was a request to state my units. It sounds…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Started this topic · Compounds › Other compounds · 8 Nov 2025 · 50 likes The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it.…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #37 · Compounds › Tirzepatide · 6 Oct 2025 · 17 likes Worth separating two things that post #33 runs together. An honest declaration on dual agonism: I have a prior here and it is strong enough that you should weight what…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 20 likes On post #90 — agreed on the reasoning, with one qualification. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published…
-
Choosing a concentration on purpose rather than by accident Started this topic · Practice › Reconstitution · 28 Sep 2025 · 0 likes On the subject in the title: Choosing a concentration on purpose rather than by accident Working notes rather than a conclusion. Working notes on choosing a…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #130 · Practice › Reconstitution · 22 Sep 2025 · 1 like Having read the whole 10 mg vial reconstituted three thread before replying: the question in the first post has not actually been answered yet, and three of us have…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #51 · Practice › Administration · 7 Sep 2025 · 0 likes Confirming post #50 from a second method, which matters more than confirming it from a second person. What I would want before treating pinch as settled: the method,…
-
Washout: how long is long enough, and for what purpose Replied, post #62 · Pharmacology › Pharmacokinetics · 2 Sep 2025 · 31 likes The documentation on washout is better than this thread and I say that as someone who has posted in the thread.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #15 · Clinical › Special populations · 29 Aug 2025 · 33 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #45 · Start Here › How to Ask · 28 Aug 2025 · 31 likes Narrowing post #42, because the general version has more than one answer. It is fine to say you cannot explain why you are asking. Nobody will press, and the technical…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #47 · Evidence › Journal club · 25 Aug 2025 · 23 likes Taking post #44 at face value and following it one step further. Orforglipron phase 2: I would want to see the raw numbers rather than the summary before agreeing.…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #33 · Analytics › HPLC & UHPLC · 11 Aug 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #9 · Practice › Side effects · 29 Jul 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Fatigue, because it is the sort of subject where it matters.
-
Temperature loggers worth the money — the long version Replied, post #8 · Devices › Cold chain · 5 Jul 2025 · 5 likes Post #5 put the caveat in the right place and I want to underline it. Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They…
-
A ten-fold dose error caught before injection Replied, post #57 · Devices › Syringes & needles · 30 Jun 2025 · 0 likes Confirming post #56 from a second method, which matters more than confirming it from a second person. Worth stating the null on ten-fold dose error caught before we…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #109 · Wellbeing › Mental health · 28 Jun 2025 · 29 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #33 · Evidence › Journal club · 25 Jun 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #130 · Access › Insurance & coverage · 15 Jun 2025 · 32 likes Taking post #128 at face value and following it one step further. Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #94 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 6 likes What I want from this Tracking intake thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #14 · Data & Tools › Calculators · 31 May 2025 · 1 like An update on my earlier titration planner refuses post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
A well-designed study with a badly written abstract Replied, post #113 · Evidence › Study critique · 28 May 2025 · 0 likes This follows post #111 rather than contradicting it. Small methodological point on well-designed study: repeating a measurement is cheap and resolves most of what is…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #16 · Devices › Pens & autoinjectors · 28 May 2025 · 0 likes Narrowing post #15, because the general version has more than one answer. Reading the dose window rather than the dial position is worth the habit. On several devices…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #60 · Compounds › Tirzepatide · 25 May 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #74 · Practice › Reconstitution · 21 May 2025 · 26 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That is where…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #90 · Access › Pricing · 6 May 2025 · 16 likes Picking up post #88: that is the part I would want checked first. Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that…
-
Follow-up: What other technical communities get right that we do not Replied, post #47 · Lounge › Off topic · 23 Mar 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
When to suspect the method rather than the sample Replied, post #99 · Analytics › Method validation · 18 Mar 2025 · 8 likes Noted, and thank you for writing it out rather than summarising it.
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #44 · Evidence › Journal club · 11 Mar 2025 · 9 likes Picking up post #43: that is the part I would want checked first. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #5 · Practice › Dosing & titration · 24 Feb 2025 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. I…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #55 · Compounds › Other compounds · 3 Jan 2025 · 0 likes Narrowing post #53, because the general version has more than one answer. What I would tell a new member reading about Research-use-only status for the first time: the…
-
Fixed versus detachable needles: the trade-offs Replied, post #81 · Devices › Syringes & needles · 30 Dec 2024 · 6 likes Safety-engineered needles are worth using if you have children or anyone else in the house, and the retraction mechanism occupies dead volume that ordinary syringes do…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #18 · Evidence › Trials · 5 Dec 2024 · 2 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Time to steady state after a dose increase Replied, post #65 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 2 likes Picking up post #63: that is the part I would want checked first. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #19 · Clinical › Prescriber conversations · 31 Oct 2024 · 26 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #5 · Practice › Interactions · 28 Oct 2024 · 13 likes This is the answer, and the reason it is the answer is the more useful part.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #116 · Clinical › Comorbidities · 27 Oct 2024 · 7 likes Adding the boring version of Hypertension improvement, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #103 · Access › Shortages · 13 Oct 2024 · 32 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing. Happy to be corrected if someone…
-
Circumference measurements as a poor man's composition estimate Replied, post #58 · Outcomes › Body composition · 11 Aug 2024 · 0 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #78 · Compounds › Retatrutide · 21 Jul 2024 · 0 likes Adding a small correction to the Retatrutide dose escalation summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…